Ent-3beta-acetoxy-7alpha,17,18-dihydroxy-15beta,16beta-epoxykaurane - Compound Card

Ent-3beta-acetoxy-7alpha,17,18-dihydroxy-15beta,16beta-epoxykaurane

Select a section from the left sidebar

Ent-3beta-acetoxy-7alpha,17,18-dihydroxy-15beta,16beta-epoxykaurane

Structure
Zoomed Structure
  • Family: Plantae - Lamiaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Diterpenoid
Canonical Smiles OC[C@@]1(C)[C@@H](CC[C@@]2(C1C[C@H](O)[C@]13C2CC[C@H](C1)[C@]1([C@@H]3O1)CO)C)OC(=O)C
InChI InChI=1S/C22H34O6/c1-12(25)27-17-6-7-19(2)14-5-4-13-9-21(14,18-22(13,11-24)28-18)16(26)8-15(19)20(17,3)10-23/h13-18,23-24,26H,4-11H2,1-3H3/t13-,14?,15?,16+,17-,18-,19+,20-,21-,22+/m1/s1
InChIKey QQJZBNLXXCQLKO-GZSKSVGUSA-N
Formula C22H34O6
HBA 6
HBD 3
MW 394.51
Rotatable Bonds 3
TPSA 99.52
LogP 1.64
Number Rings 5
Number Aromatic Rings 0
Heavy Atom Count 28
Formal Charge 0
Fraction CSP3 0.95
Exact Mass 394.24
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Sideritis moorei Lamiaceae Plantae 3394641

Showing of synonyms

  • Ghoumari H, Benajiba MH, et al. (2005). ent-Kauranoid derivatives from Sideritis moorei. Phytochemistry,2005,66(12),1492-1498. [View] [PubMed]
Pubchem: 162887989

No compound-protein relationship available.

Structure

SMILES: C123C4C(O4)C(C1)CCC2C5C(CC3)CCCC5

Level: 0

Mol. Weight: 394.51 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.22
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.73
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.59

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.25
Plasma Protein Binding
42.14
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
12.83
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Toxic
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-0.68
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-0.34
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
5.55
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-20.24
Rat (Acute)
2.88
Rat (Chronic Oral)
2.01
Fathead Minnow
3.77
Respiratory Disease
Toxic
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Toxic
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
469.75
Hydration Free Energy
-5.75
Log(D) at pH=7.4
1.44
Log(P)
1.46
Log S
-3.14
Log(Vapor Pressure)
-8.61
Melting Point
169.47
pKa Acid
6.38
pKa Basic
7.0
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Aldo-keto reductase family 1 member C2 P52895 AK1C2_HUMAN Homo sapiens 3 0.8805
Aldo-keto reductase family 1 member C2 P52895 AK1C2_HUMAN Homo sapiens 3 0.8805
Nuclear receptor subfamily 1 group I member 2 O75469 NR1I2_HUMAN Homo sapiens 3 0.7245
Nuclear receptor subfamily 1 group I member 2 O75469 NR1I2_HUMAN Homo sapiens 3 0.7245

Download SDF